baber/WOPTO huggingface dataset:
Patent PE-37897-A1 (PE)
Title: Agentes antifungicos de peptidos ciclicos
Inventor: BORROMEO PETER STANLEY
IPC: C07K7/56
Filed: 1996-05-22
Abstract: SE REFIERE A PEPTIDOS CICLICOS SEMISINTETICOS DE FORMULA (I), DONDE R`, R" Y R"' SON CH3 O H O R' ES -CH2C(O)NH2; Rx1, Rx2, Ry1, Ry2, Ry3 Y Ry4 SON -OH O -H O Rx1 ES -OR DONDE R ES ALQUILO(C1-C6) O BENCILO, ENTRE OTROS; Ro ES -OH, -OP(O)(OH)2, -OP(O)(OH)(R1) O -OP(O)(OH)(OR1); R1 PREFERENTEMENTE ES -CH3; R2 ES UN COMPUESTO DE FORMULA (II), EN DONDE R2a PREFERENTEMENTE ES METILO, HALO O METOXI Y a ES 1, 2, 3 o 4, PREFERENTEMENTE 1; R3 PREFERENTEMENTE ES ALCOXI (C1-C12) O -O-(CH2)-[0]-ALQUILO(C1-C12). TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I), QUE COMPRENDE LA ACILACION DEL COMPUESTO (I) EN LA POSICION DEL SUSTITUYENTE R2, DONDE R2 ERA INICIALMENTE HIDROGENO. ESTOS COMPUESTOS TIENEN ESTABILIDAD Y SOLUBILIDAD MEJORADA EN EL AGUA, SIENDO USADOS EN EL TRATAMIENTO DE INFECCIONES FUNGICAS DEL GENERO CANDIDA O ASPERGILLUS, ADEMAS DE INFECCIONES OPORTUNISTAS EN INDIVIDUOS INMUNOSUPRIMIDOS, CAUSADA POR PNEUMOCYSTIS CARINII
Patent PE-101399-A1 (PE)
Inventor: SAMUELSSON ANN
IPC: A61F13/15
Filed: 1998-06-22
Abstract: An absorbent article such as a sanitary napkin, an incontinence pad, panty liner or the like, which article is intended to be substantially accommodated within a user's panties and comprising an absorbent upper part (2) and an absorbent lower part (3), which two parts are mutually joined in such a manner that the article, at least in its mid portion (26), presents an elongate cavity between the upper part (2) and the lower part (3) which is maintained during use.
Patent PE-103598-A1 (PE)
Inventor: WONG DENNIS T H
IPC: F16L58/10
Filed: 1997-11-18
Abstract: Pipe 12 coated at 17 with a hot plastic coating is cooled by applying a liquid cooling medium to the interior of the pipe. The cooling medium may be sprayed in zone 23 from a lance 21 connected  to  a self  propelled  car t 18 carrying rechargable pressurised reservoirs 24 for the cooling medium. The cart is stationary relative to the outside and moves internally relative to sections of pipe that pass successively through the coating and cooling stations. The lance may alternatively be connected to a supply of cooling medium rearward of the trailing end of the pipe.
Patent PE-21696-A1 (PE)
Inventor: ROMARE ANETTE
IPC: A61F5/44
Filed: 1995-04-12
Abstract: PCT No. PCT/SE95/00389 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Apr. 11, 1995 PCT Pub. No. WO95/27460 PCT Pub. Date Oct. 19, 1995A pant diaper or a sanitary panty which includes a front part, a rear part, and an intermediate crotch part, which includes an absorbent body enclosed between an inner and an outer casing sheet. The front part is detachably joined to the rear part by means of a first fastening. A piece of flexible material extends over the front part and is joined thereto over a larger part of its surface by means of a first releasable fastening, which extends on both sides of a centrally located region of the piece of material, from the edges of the central region to the respective side edges of the front part. The piece of material is also joined to the rear part.
Patent PL-223389-A1 (PL)
Inventor: HARRIS NORMAN
IPC: C07D307/08
Filed: 1980-04-11
Abstract: Tetrahydrofuran is produced by converting allyl alcohol to an allyl t-alkyl or -cycloalkyl ether of the general formula:   <IMAGE> (III) wherein R1 and R2 each, independently of the other, represent a C1 to C4 alkyl radical, and R3 and R4 each, independently of the other, represent a hydrogen atom or a C1 to C3 alkyl radical, or wherein R1 represents a C1 to C4 alkyl radical, R2 and R3 together with the carbon atoms to which they are attached form a 5-membered or 6-membered cycloaliphatic ring, and R4 represents a hydrogen atom or a C1 to C3 alkyl radical, followed by reacting resulting compound of formula (III) under hydroformylation conditions with carbon monoxide and hydrogen in the presence of a hydroformylation catalyst to form a corresponding aldehyde-ether of the general formula:    <IMAGE> (I) reducing resulting aldehyde-ether of the general formula (I) a corresponding hydroxy-ether of the general formula:   <IMAGE> (II) and cleaving resulting hydroxy-ether of the general formula (II) under dehydrating conditions to produce tetrahydrofuran. Typically R1 and R2 each represent a methyl group while R3 and R4 each represent a hydrogen atom. The alkene of the general formula:   <IMAGE> (IV) released upon cleavage of the hydroxy-ether of formula (II) can be recycled for reaction with further allyl alcohol to form a further quantity of the ether of the general formula (III).
Patent PL-255391-A1 (PL)
Title: Method of obtaining pregnane derivatives
IPC: C07J63/00
Filed: 1985-09-16
Abstract: Known pregnane derivatives are prepared by esterificiation of known androstane derivatives to give new ester of Formula III    <IMAGE> (III)  wherein    in each case symbolizes a single bond or a double bond, n is 1 or 2, R1 is hydrogen or methyl, R2 is hydrogen or formyl, and R3 is chlorine, hydroxy or an alkanoyloxy group of up to 6 carbon atoms, and reaction of the latter with Ag(I) and formic acid.
Patent PL-286374-A1 (PL)
Title: Apparatus for cutting fruits, vagatables and the like into slices
Inventor: BORNER JURGEN
IPC: B26D3/24
Filed: 1990-08-06
Abstract: The invention is directed to a device for cutting fruit, vegetables or the like into slices, comprising a blade-holding plate at whose leading edge a V-shaped cutter blade is arranged, comprising two framing ledges arranged essentially parallel that are connected to one another by the blade-holding plate and by at least one further transverse web, and comprising a slide plate guided at the framing ledges and introducible parallel to the blade-holding plate, whereby a narrow gap remains between the back edge of the slide plate and the cutter blade. It is inventively provided that a support plate (11) fashioned as a closed surface is arranged under the slide plate (6) in order to increase the stability of the slide plate, particularly to counter sagging when pressure is exerted on the material to be cut.
Patent PL-301012-A1 (PL)
Title: Extract from bacterial macromolecules, method of preparing same and pharmaceutical composition containing it
Inventor: BAUER JACQUES
IPC: A61K35/74
Filed: 1993-02-03
Abstract: PCT No. PCT/CH93/00029 Sec. 371 Date Sep. 20, 1993 Sec. 102(e) Date Sep. 20, 1993 PCT Filed Feb. 3, 1993 PCT Pub. No. WO93/16190 PCT Pub. Date Aug. 19, 1993.An extract based on modified bacterial proteins includes a mixture of acid bacterial polyanions having a molecular weight in the range from 10,000 to 1,000,000 and an isoelectric point in the range from 2.5 to 5.5, and in which the added weights of the constituent amino acids amount to at least 50% of the extract. The preparation or this protein extract includes a cultivation of bacteria in an aqueous medium and then the alkaline extraction of this bacterial suspension and the purification of the protein extract. The alkaline extraction is carried out in the presence of a dilute aqueous source of OH- ions and at a stable pH in the range from 11 to 13, the decrease of this pH during the acid extraction not exceeding 0.4. The protein extract thus obtained can be used as an active ingredient in a pharmaceutical composition.
Patent PL-305457-A1 (PL)
Title: Galantamine derivatives, method of obtaining them and their application as drugs
Inventor: KOSLEY RAYMOND W JR
IPC: C07D307/26
Filed: 1994-10-14
Abstract: This application relates to compounds of the formula <CHEM> wherein R<1>, R<2> and R<3> are defined within, which compounds are useful for the treatment of memory dysfunction characterized by decreased cholinergic function, pharmaceutical compositions containing the compounds and methods for making and using the compounds.
Patent PL-307341-A1 (PL)
Title: Method of as well as reagent and kit for detecting and amplifying a sequence of nucleic acids
Inventor: ADAMS CRAIG W
IPC: C12Q1/68
Filed: 1993-08-04
Abstract: Methods and reagents for the detection and exponential amplification of target nucleic acid molecules are disclosed. The method generally employs a Primer Oligonucleotide which hybridizes in concert with a Blocker Oligonucleotide on a strand of the target molecule, and an End-Run Oligonucleotide which can hybridize to the Blocker Oligonucleotide.
Patent PL-314134-A1 (PL)
Title: Inhibitors of intercellular substance protease
Inventor: CASTELHANO ARLINDO L
IPC: C07C255/60
Filed: 1994-11-03
Abstract: This invention is directed to compounds of formula (I): wherein R<1> is mercapto, acetylthio, carboxy, hydroxycarbamoyl, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, benzyloxycarbamoyl or (i) (where R<6> is optionally substituted aryl, wherein the aryl group is quinol-2-yl, naphth-1-yl, naphth-2-yl, pyridyl or phenyl); R<2> is alkyl, aralkyl or cycloalkylalkyl; R<3> is cycloalkyl, alkyl (optionally substituted by cycloalkyl, hydroxy, mercapto, alkylthio, aralkoxy, carboxy, amino, alkylamino, guanidino, carbamoyl, pyridyl or indolyl), or aralkyl (optionally substituted by hydroxy, carboxy, alkyl or alkoxy); R<4> is nitro, amino, cyano, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkylsulfonyl, haloalkyl, alkoxycarbonylalkyl, tetrazolyl, carbamoyl (optionally substituted by alkyl or dialkylaminoalkyl), or aminosulfonyl (optionally substituted by alkyl); and R<5> is hydrogen, halo or hydroxy; as single stereoisomers or as mixtures thereof; or the pharmaceutically acceptable salts thereof. These compounds are useful in inhibiting matrix metalloprotease activity in mammals.
Patent PL-317189-A1 (PL)
Title: Heat exchanger
Inventor: LANGOY JOSTEIN
IPC: F28D7/02
Filed: 1995-05-05
Abstract: PCT No. PCT/NO95/00075 Sec. 371 Date Feb. 4, 1997 Sec. 102(e) Date Feb. 4, 1997 PCT Filed May 5, 1995 PCT Pub. No. WO95/30870 PCT Pub. Date Nov. 16, 1995A heat exchanger has been developed with a helical insert (9) permanently mounted in a housing (2). Between the windings in the insert (9) there is formed a helical channel (20) for one heat exchange medium. The insert (9) is designed with a channel (10) for the second heat exchange medium. The heat exchanger is designed with a central tube (13) which is axially movable and rotatable. The central tube (13) is designed with scraper elements for removal of deposits in the channel (20). In one embodiment the scraper element is formed by a helical insert (15) of the same design as the insert (9). The insert (15) is designed with a channel (16) for the second heat exchange medium. In a further embodiment the central tube (13) is designed with one or more scraper arms (23) which may be liquid-cooled. Deposits are often formed on the heat transfer surfaces. A cleaning cycle is performed by means of axial movement of the insert (15) which is mounted on the central tube (13) towards the permanently mounted insert (9), thus causing the heat transfer surfaces to touch each other. A rotating movement is then performed, e.g., a part of a turn, while the surfaces are close to each other or in contact with each other, thus causing the deposits on the two surfaces to be rubbed or scraped off and thereby cleaning the channel (20).
Patent PL-318327-A1 (PL)
Title: Heterocyclic antagonists of tachykinin receptors
Inventor: CHO SUNG-YONG STEPHEN
IPC: A61P13/02
Filed: 1995-06-30
Abstract: This invention provides the novel compound of the following formula   <CHEM> having the chemical name (R)-3-(1H-indol-3-yl)-1-ÄN-(2-methoxybenzyl)acetylaminoÜ-2-ÄN-(2-(4-(p iperidin-1-yl)piperidin-1-yl)acetyl)aminoÜpropane dihydrochloride trihydrate.
Patent PL-323822-A1 (PL)
Title: Polysaccharidic fragments of streotococcus type ii and type iii from antigenic group b processing terminal structure of 2,5-anhydro-d-mannose and conjugated cavvine made on their basis
Inventor: MICHON FRANCIS
IPC: C07K/
Filed: 1996-06-06
Abstract: The process for depolymerizing Group B Types II and III Streptococcal Polysaccharide is disclosed which results in polysaccharide fragments having a reducing end suitable for conjugating to protein. Conjugate molecules, vaccines and their use to immunize mammals including humans are also disclosed.
Patent PL-339690-A1 (PL)
Title: Novel aminotriazole compounds, method of obtaining them and pharmaceutic compositions containing such compounds
IPC: C07D409/12
Filed: 2000-04-14
Abstract: 1,2,4-Triazolylamino-substituted carboxamide or hydrazide derivatives (I) are new. Triazole derivatives of formula G-NH-A- CO-NH-(NH)n-W-Z (I) and their enantiomers, diastereoisomers and acid or base addition salts are new. G = 1,2,4-triazolyl group of formula (G1)-(G4); n = 0 or 1; W = CO, S, SO or SO2; Z, R1 = alkyl or (all optionally substituted) aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroaralkyl, heteroaralkenyl or heteroaralkynyl; A = -A2-, -A1-A-2-, -A2-A1- or -A1-A2-A1-; A1 = alkylene; A2 = phenylene, naphthylene, cycloalkylene or heteroarylene (all optionally substituted); R = H or as Z. Alkyl or alkylene groups have 1-6C; alkenyl/alkynyl groups have 2-6C and 1-3 double/triple bonds; cycloalkylene groups have 3-6C; aryl groups are phenyl, naphthyl, biphenylyl, dihydronaphthyl or tetrahydronaphthyl; heteroaryl moieties are 5-11 membered, mono- or bicyclic and unsaturated or partially unsaturated, and contain 1-4 of O, S and N as heteroatoms; arylene or heteroarylene moieties are the divalent analogs of arylene and heteroarylene respectively; optionally substituted, in the case of aryl, aralkyl, heteroaryl and heteroaralkyl, indicates that the groups are optionall ring-substituted by 1-5 of alkyl, alkoxy, halo, OH, perhaloalkyl, NO2, NH2, mono- or dialkylamino, 1-6C acyl, CONH2, mono- or di-alkylaminocarbonyl, 1-6C acylamino, alkoxycarbonyl, CHO, COOH, SO3H, CN, aminoalkyl, mono- or dialkylaminoalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl or alkoxyalkyl; optionally substituted, in the case of phenylene, naphthylene and heteroarylene, indicates that the groups are optionally substituted by 1-3 of alkyl, alkoxy, halo, OH, perhaloalkyl, NO2, NH2, mono- or dialkylamino, 1-6C acyl, CHO, COOH, alkoxycarbonyl, CONH2, mono- or di-alkylaminocarbonyl, 1-6C acylamino or CN. An Independent claim is included for the preparation of (I).
Patent PL-343365-A1 (PL)
Title: Polyene macrolide derivatives, use for vectoring molecules
Inventor: BOLARD JACQUES
IPC: C12N15/87
Filed: 1999-04-07
Abstract: A composition having a negatively charged molecule and a cationic polyene macrolide compound having two to four positive charges that reacts with the negatively charged molecule is described. This compound can be used to vector molecules and especially nucleic acids into cells.
Patent PL-346408-A1 (PL)
Title: Tarpaulin fixture
Inventor: FLIEGE DIETER
IPC: B60J7/06
Filed: 1999-09-01
Abstract: The invention relates to a tarpaulin fixture for canopies of utility vehicles, notably folding canopies for vehicle superstructures and containers, comprising a canopy frame made of upper longitudinal booms (2) which cover the length of the loading area and are supported in relation to the vehicle chassis by means of a upright supports and stakes. Bows (3) which can be displaced in the longitudinal direction of the vehicle and support a roof cover, notably a tarpaulin, are supported on the upper longitudinal booms (2) of the canopy frame in such a way that their end faces or caps (4) placed onto same laterally overlap the longitudinal booms (4). Especially side wall tarpaulins are fixed by irremovable clips passing through eyelets or at least recesses in the tarpaulin to support elements, such as the fixing plate of suspension slides or bow caps, arranged at intervals to each other.
Patent PL-348222-A1 (PL)
Title: Method of automatically and centrally assembling moulded components to be assembled together
Inventor: NILI TIZIANO
IPC: B29C69/00
Filed: 2001-06-21
Abstract: A process for the automatic and centered assembly of molded parts (1, 2) for the realization of articles such as acoustic boxes of motor-vehicles, which process comprises the production of said molded parts (1, 2) by hot molding, and is provided with integral aligning and engagement means, and the coupling of said molded parts (1, 2) by embedding said integral alignment and engagement means directly after the forming and before the cooling of said parts, in order to compensate the different shrinkage ensuing from their different geometry. <IMAGE>
Patent PL-348888-A1 (PL)
Title: 3-(heterocyclyl)-substituted benzoylpyrazols
Inventor: NEIDLEIN ULF
IPC: C07D231/20
Filed: 1999-12-02
Abstract: The invention relates to 3-(heterocyclyl)-substituted benzoylpyrazois of formula (I), wherein the variables have the following meanings: X is O, NH or N-alkyl; R<1 >is alkyl; R<2>, R<3>, R<4>, R<5 >are hydrogen, alkyl or alkyl halide; R<6 >is halogen, nitro, alkyl halide, alkoxy, halogenalkoxy, alkylthio, halogenalkylthio, alkylsulfonyl or halogenalkylsulfonyl; R<7 >is hydroxy, alkoxy, alkenyloxy, alkylsulfonyloxy, alkylcarboyloxy, alkylthiocarbonyloxy, phenylsulfonyloxy or phenylcarbonyloxy, and the phenyl radical can be substituted; R<8>, R<9 >are alkyl; R<10 >is hydrogen or alkyl; and R<11 >is hydrogen or alkyl; and to their agriculturally useable salts. The invention also relates to intermediate products and methods for producing the inventive compounds and to the use of these compounds or products containing them for combating undesirable plants.
Patent PL-353066-A1 (PL)
Title: Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
Inventor: SCHOELKENS BERNWARD
IPC: A61K31/403
Filed: 2000-08-25
Abstract: Novel use of an inhibitor of the renin-angiotensin system or derivative (I) in the manufacture of a medicament for the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. Independent claims are also included for: a method of preventing of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF; and a formulation for use in the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. ACTIVITY : Cerebroprotective; Cardiant; Antidiabetic. Treating 9,541 patients who are at risk for cardiovascular events due to a history of previous ischemic heart disease, stroke, peripheral arterial disease or individuals with diabetes with ramipril for 6 years resulted in a 32% reduction in the number of patients who developed a stroke, 21% who developed congestive heart failure, and 36% reduction who developed diabetes. MECHANISM OF ACTION : Angiotensin converting enzyme (ACE) inhibitor; an angiotensin II antagonist.
Patent PL-362323-A1 (PL)
Title: Pharmaceutical preparation comprising an active dispersed on a matrix
Inventor: DIETRICH RANGO
IPC: A61K31/4439
Filed: 2001-12-06
Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation, an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohols, triglycerides, partial triglycerides and fatty acid esters.
Patent PL-363556-A1 (PL)
Title: Appliance containing vacuum filler and clamping module and method of fitting clamp of any type on a housing
Inventor: MULLER GERHARD
IPC: A22C11/00
Filed: 2003-11-19
Abstract: The apparatus, to fill a sausage skin (4) with a paste mass, has a vacuum filler (3) and a clip module (1) to fit clips (2) to the filled skin at intervals. The drive for the clip module is operated by the vacuum filler, to apply the clips where the sausage portions are defined. The clip module has a rotary unit (5) which is driven by a rotary drive (8) from a servo motor (9) at the vacuum filler, with a horizontal drive shaft (6) between them. The clip module has a displacement unit (7) and a system to lay a thread or a loop.
Patent PL-363579-A1 (PL)
Title: Transom-mullion structure
Inventor: HOCKER EITEL-FRIEDRICH
IPC: E04B2/96
Filed: 2002-01-10
Abstract: A structure with vertical members and cross members, particularly for facades or light-transparent roofs, in whose frame area glass panes ( 100 ) can be inserted, comprises several vertical members ( 1 ) between which cross members ( 2 ) are fixed. Channels ( 3, 4 ) are provided on the outer surface of the vertical members ( 1 ), specifically on the edges thereof, and serve to accommodate a seal ( 5, 6 ), whereby a drainage channel ( 7, 8 ) for diverting liquid is arranged adjacent to the channel ( 3, 4 ). In addition, channels ( 10, 11 ) are provided on the side of the cross member ( 2 ), specifically on the edges thereof, that faces the outer surface of the vertical member ( 1 ), and serve to accommodate a seal ( 12 ) and a retaining strip ( 13 ) located between the channels ( 10, 11 ). According to the invention, a connecting part ( 40 ) is attached to the cross member ( 2 ) at the face thereof and serves to lengthen the channels ( 10, 11 ) and the retaining strip ( 13 ) of the cross member ( 2 ) while at least partially overlapping the channel ( 3 ) located on the edge of the vertical member. This configuration enables the cross member to be easily attached to the vertical member, whereby, for providing an overlapping design of the cross member, a connecting part is easily mounted without requiring a complex notching of the cross member ( 2 ).
Patent PL-367081-A1 (PL)
Title: Dna-pk inhibitors
Inventor: GRIFFIN ROGER JOHN
IPC: C07D413/04
Filed: 2002-08-14
Abstract: The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R1 and R2 are independently hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR4 and O, O and CR′4 and NR″4 and N, where the unsaturation is in the appropriate place in the ring, and where one of R3 and R4 or R′4 is an optionally substituted C3-20 heteroaryl or C5-20 aryl group, and the other of R3 and R4 or R′4 is H, or R3 and R4 or R″4 together are —A—B—, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM.
Patent PL-395664-A1 (PL)
Inventor: KUCINSKA-LIPKA JUSTYNA
IPC: C08J9/12
Filed: 2011-07-15
Abstract: Sposób otrzymywania pianek poliuretanowych polegający na tym, że tworzy się mieszaninę reakcyjną zawierającą komponent poliolowy, porofor i komponent izocyjanianowy zawierający niezwiązane grupy izocyjanianowe w ilości 8-48% wag. charakteryzuje się według wynalazku tym, że łączy się komponent izocyjanianowy z komponentem poliolowym w temperaturze 20-110°C w stosunku równoważnikowym grup izocyjanianowych do sumy aktywnych atomów wodoru 0,6/1 do 4/1, korzystnie od 0,7/1 do 3/1. Jako komponent izocyjanianowy stosuje się izocyjaniany i/lub mieszaniny izocyjanianów alifatycznych i/lub aromatycznych, korzystnie polimeryczny diizocyjanian difenylometanu i/lub 4,4'-diizocyjanian difenylometanu. Do mieszaniny reakcyjnej dodaje się porofor w postaci białka zwierzęcego, przy czym reakcje prowadzi się w obecności katalizatorów w postaci III-cio rzędowych amin i/lub organicznych związków metali w stosunku co najwyżej do 1% wag. komponentu poliolowego, oraz dodaje się związki powierzchniowo czynne, korzystnie związki silikonowe, w stosunku co najwyżej do 0,5% wag. komponentu poliolowego.